REM Sleep Behavior Disorder (RBD) is a disorder in which people talk or move during their dreaming sleep. People living with RBD often - but not always - develop an overt neurodegenerative disorder, such as Parkinson’s disease, dementia with Lewy bodies or multiple system atrophy.

  • Do you act out your dreams? Are you living with RBD?

    Do you act out your dreams? Have you been diagnosed with REM Sleep Behavior Disorder? Explore resources and opportunities to participate in research.

    Learn More About RBD

  • Are you a healthcare provider or industry partner?

    Learn more about REM Sleep Behavior disorder diagnosis and clinical management and explore active areas of research in synucleinopathies.

    Resources for Healthcare Professionals

  • REMEDY | REM Sleep Behavior Disorder Education Delivery

    REMEDY is an educational portal offering information on RBD, clinical studies, research opportunities, and resources for patients, loved ones, physicians, and researchers.

    Explore Our Educational Portal

 Our Mission

The purpose of the North American Prodromal Synucleinopathy (NAPS) Consortium is to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Through these efforts, we aim to develop treatments that will delay the onset of, or prevent the development of, neurodegenerative disorders associated with RBD.

 

Join the RBD Registry

The NAPS Consortium on REM Sleep Behavior Disorder (RBD) has established a registry for individuals living with RBD, partners and family of someone diagnosed with RBD, and those wanting to learn more about RBD.

This information is used to identify study participants, assist care teams providing care to individuals with RBD and to study RBD treatments and outcomes.

 

Your privacy is important to us. All personal health information (PHI) is protected and stored in a HIPAA compliant system.

Organizations That Support Diseases Related to RBD

logos.jpg
logos2.jpg
logos3.jpg
logos4.jpg
logos5.jpg
RBD Question of the Week❓💤💡 ⎯ This week, we have Drs. Roneil Malkani from Northwestern University and Ron Postuma from McGill University to answer one of our most pressing RBD questions. ⎯ Q: How confident are you in predicting phenoconversion/tran
The NAPS Investigator Meeting kicked off today in Los Angeles, with presentations reviewing data collected from NAPS participants. 527 people have completed 1134 NAPS visits! We are extremely grateful to our participants for their effort and time tha
A recent study finds that poor sleep quality is linked to accelerated brain aging. Among the 589 participants, those exhibiting two to three sleep issues showed an average brain age 1.6 years older, while those with more than three issues had an ave
RBD Question of the Week❓💤💡 ⎯ This week, we have Drs. Roneil Malkani from Northwestern University and Ron Postuma from McGill University to answer one of our most pressing RBD questions. ⎯ Q: Is there a specific treatment to prevent neurodegenerati
Memory loss is the most recognized symptom of dementia, particularly in Alzheimer's disease, but experts point out other early warning signs that are significant for types of dementia where forgetfulness isn't primary. Additionally, while older adult
Together, we’re making strides towards a brighter future in neurodegenerative disease research! 💡🔬🧠 We recently wrapped up our second Industry Roundtable at the Movement Disorders Society Congress in Philadelphia. Our focus? Advancing clini
A recent study from the Netherlands examined the link between benzodiazepine use and long-term dementia risk in cognitively healthy older adults. 💊🧠📉 This large study of >5000 individuals found no association between bezodiazepine usage and de
Many Americans are turning to social media for sleep advice, with 37% of adults trying at least one viral sleep trend in 2024, according to a survey by the @aasmorg. Experts caution that while some trends, like "bed rotting" and magnesium d